Crystalline Form Ii Of Anagrelide Hydrochloride Monohydrate

Patent No. EP2945948 (titled "Crystalline Form Ii Of Anagrelide Hydrochloride Monohydrate") was filed by Synthon on Jan 16, 2014. The application was issued on Apr 29, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEJan 29, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2945948

SYNTHON
Application Number
EP14700674A
Filing Date
Jan 16, 2014
Status
Opposition Rejected
Oct 21, 2022
Publication Date
Apr 29, 2020